IE40824B1 - New antibiotics - Google Patents
New antibioticsInfo
- Publication number
- IE40824B1 IE40824B1 IE534/75A IE53475A IE40824B1 IE 40824 B1 IE40824 B1 IE 40824B1 IE 534/75 A IE534/75 A IE 534/75A IE 53475 A IE53475 A IE 53475A IE 40824 B1 IE40824 B1 IE 40824B1
- Authority
- IE
- Ireland
- Prior art keywords
- water
- approxiamtely
- accompanying drawings
- absorption
- butanol
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Cephalosporin Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A process for the preparation of an antibacterially active carboxylic acid compound designated as MM 13902 and salts thereof, which substance MM 13902 is sold carbxylic acid characterised in that its pure di-sodium salt; (i) is highly soluble in water, soluble in methanol and substantially insolubel in chloroform, diethylether and hydro-carbons; (ii) in aqueous solution has an ultra-violet spectrum substnatially as shown in Fig. 1 of the accompanying drawings with absorption maxima at about 305 and 225 mm; (iii) when present at 0.4% w/w in a freshly prepared KBr disc has an infra-red absorption spectrum substantially as shown in Fig. 2, of the accompanying drawings with absorption maxima at inter alia about 3450, 2950, 1750, 1620, 1510, 1400 and 1260cm1; (iv) has an n.m.r. specturm substantially as shown in Fig. 3 of the accompanying drawings when taken in a freshly prepared solution in D2O with inter alia (a) a pair of low fiedl doubelts centred at approximately 2.85GAMMA and 4.00GAMMA with coupling constants of approxiamtely 14 Hz; (b) a doublet centered at approxiamtely 8.55 and (c0 a sharp signlet at approxiamtely 8.00; (v) has the following approxdiamte Rf values ethn run on a cellulose thiin layer chromatogrpahy system; (a) n_butanol/ isopropanol/ water-7:7:6 v/v; Rf=0.72 (b) isopropanol/water-7:3 v/v; Rf=0.85 (c) n-butanol/ethanol/water-7:7:6 v/v; Rf0.81 (d) n-propanol/water-4:1; Rf=0.75; (vi) has an I50 of between 0.001/ug/ml and 0.0001/ug/ml against the beta-lactamase of Escherichia coli B11; (vii) synergises the activity of ampicillin against organisms includign strains of Escherichia coli, Klebnsiella aerogenes, Proteus mirabills, Proteus morganii and Staphylococcus aureus Russell; which process comprises the aerobic grouth of a MM 13902 producing strain of Streptomyces in the presence of assimilable soruces of cabron, nitrogen, sulphur and mineral salts in a solid or semi-solid nutritive medium or in a liquid medium in which the nutrients are dissovled or supsended, at a temperature of 28+/-2degree C for 2 to 3 days and thereafter extracting the antibiotics opresent from the culture medium, either by initial absorption on to and then elution from active characoal or an ion-exchange resin cotnaining tertiary amino grous or quternary ammonium groups or by extracting into a solution of a lipophilic ammonium salt in a water immiscible soluvent at a temperature not exceeding 20degrees C and separatign the MM 13902 therefrom by column chromatograpohy either by using a cellulose or silica-gel column and eluting eith mixtures of water with water-miscible organic solvents or by using columns of ion-exchange resins containing tertiary amino grouups or quarternary ammonium groups and eluting with aqueous solutions of electrolytes buffered to appropriate neutrality. [IN141262A1]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB13856/74A GB1489235A (en) | 1974-03-28 | 1974-03-28 | Antibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
IE40824L IE40824L (en) | 1975-09-28 |
IE40824B1 true IE40824B1 (en) | 1979-08-29 |
Family
ID=10030627
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE604/75A IE40864B1 (en) | 1974-03-28 | 1975-03-19 | Antibiotics |
IE534/75A IE40824B1 (en) | 1974-03-28 | 1975-03-19 | New antibiotics |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE604/75A IE40864B1 (en) | 1974-03-28 | 1975-03-19 | Antibiotics |
Country Status (15)
Country | Link |
---|---|
CS (1) | CS199264B2 (en) |
DD (1) | DD116852A5 (en) |
DK (1) | DK140150B (en) |
ES (1) | ES436104A1 (en) |
FI (1) | FI55352C (en) |
HU (1) | HU170786B (en) |
IE (2) | IE40864B1 (en) |
IL (1) | IL46837A (en) |
IN (1) | IN141262B (en) |
NO (1) | NO144394C (en) |
NZ (1) | NZ176970A (en) |
PL (1) | PL94006B1 (en) |
SU (1) | SU528038A3 (en) |
YU (1) | YU79275A (en) |
ZA (1) | ZA751934B (en) |
-
1975
- 1975-03-14 IL IL46837A patent/IL46837A/en unknown
- 1975-03-15 IN IN515/CAL/1975A patent/IN141262B/en unknown
- 1975-03-19 IE IE604/75A patent/IE40864B1/en unknown
- 1975-03-19 NZ NZ176970A patent/NZ176970A/en unknown
- 1975-03-19 IE IE534/75A patent/IE40824B1/en unknown
- 1975-03-26 NO NO751075A patent/NO144394C/en unknown
- 1975-03-26 DK DK132875AA patent/DK140150B/en unknown
- 1975-03-26 DD DD185036A patent/DD116852A5/xx unknown
- 1975-03-26 ES ES436104A patent/ES436104A1/en not_active Expired
- 1975-03-26 ZA ZA00751934A patent/ZA751934B/en unknown
- 1975-03-27 SU SU2123702A patent/SU528038A3/en active
- 1975-03-27 CS CS752120A patent/CS199264B2/en unknown
- 1975-03-27 FI FI750958A patent/FI55352C/en not_active IP Right Cessation
- 1975-03-28 PL PL1975179170A patent/PL94006B1/pl unknown
- 1975-03-28 HU HU75BE00001222A patent/HU170786B/en unknown
- 1975-03-28 YU YU00792/75A patent/YU79275A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK140150C (en) | 1979-11-26 |
NZ176970A (en) | 1981-03-16 |
FI55352C (en) | 1979-07-10 |
IL46837A0 (en) | 1975-05-22 |
IN141262B (en) | 1977-02-05 |
DK132875A (en) | 1975-09-29 |
IE40864L (en) | 1975-09-28 |
SU528038A3 (en) | 1976-09-05 |
IE40824L (en) | 1975-09-28 |
CS199264B2 (en) | 1980-07-31 |
IL46837A (en) | 1978-07-31 |
HU170786B (en) | 1977-09-28 |
ES436104A1 (en) | 1977-07-01 |
YU79275A (en) | 1982-02-28 |
DD116852A5 (en) | 1975-12-12 |
NO144394B (en) | 1981-05-11 |
NO751075L (en) | 1975-09-30 |
NO144394C (en) | 1981-08-19 |
ZA751934B (en) | 1976-04-28 |
FI750958A (en) | 1975-09-29 |
IE40864B1 (en) | 1979-08-29 |
DK140150B (en) | 1979-06-25 |
FI55352B (en) | 1979-03-30 |
PL94006B1 (en) | 1977-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Haneishi et al. | Oxazinomycin, a New Carbon-Linked Nugleoside Antibiotic | |
GB1376983A (en) | Enzyme stabilization | |
Ishibashi | Studies on antibiotics from Helminthosporium sp. fungi. VII Siccanin, a new antifungal antibiotic produced by Helminthosporium siccans | |
US3207755A (en) | Transformation products of cephalosporin c and derivatives thereof | |
IE36881L (en) | 7, 7-disubstituted cepalosporins and 6, 6-disubstituted¹penicillins | |
US4261977A (en) | Streptomycetal antibiotic | |
IE40824B1 (en) | New antibiotics | |
GB1387212A (en) | Turf maintenance machine | |
GB932898A (en) | A process for the production of 5-nucleotides | |
US3733320A (en) | Antibiotic purification processes | |
CA1153968A (en) | Antibiotic pa-31088-iv and production thereof | |
IE37892B1 (en) | Antibiotic a-2315 and process for preparation thereof | |
US3219662A (en) | Transformation products of cephalosporin c and derivatives thereof | |
Yagishita | Production of Phenazine Compounds by Stretomyces Griseoluteus | |
NL151436B (en) | PROCESS FOR PREPARING AN ANTIBIOTIC BY A STREPTOMYCETE, OF THE SPECIES STREPTOMYCES RIMOSUS. | |
GB1156390A (en) | Polyoxin Antibiotics and process for preparing the same | |
ES468942A1 (en) | Method for producing cepham compounds | |
US4163051A (en) | Streptomycetal antibiotic | |
GB1356723A (en) | Antibiotic sf-1293 substance and its production and uses | |
ES451318A1 (en) | Fermentation of cephamycin C | |
SU420153A3 (en) | METHOD OF ISOLATION AND / OR CLEANING OF CEFAMICINE C | |
GB757089A (en) | Improvements in or relating to antibiotics | |
JPS57102890A (en) | Beta-lactam antibiotic pa-31088-ii and its preparation | |
Phillips et al. | Some 7-Substituted Derivatives of 8-Quinolinol | |
CA1142468A (en) | Antibiotic sf-2050 and sf-2050b substances and production and use thereof |